170 related articles for article (PubMed ID: 7956947)
1. Expression of transforming growth factor-beta 1 in prostate cancer.
Steiner MS; Zhou ZZ; Tonb DC; Barrack ER
Endocrinology; 1994 Nov; 135(5):2240-7. PubMed ID: 7956947
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta 1 overproduction in prostate cancer: effects on growth in vivo and in vitro.
Steiner MS; Barrack ER
Mol Endocrinol; 1992 Jan; 6(1):15-25. PubMed ID: 1738367
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer.
Eastham JA; Truong LD; Rogers E; Kattan M; Flanders KC; Scardino PT; Thompson TC
Lab Invest; 1995 Nov; 73(5):628-35. PubMed ID: 7474936
[TBL] [Abstract][Full Text] [Related]
4. Expression of transforming growth factor-beta 1 in rat ventral prostate and Dunning R3327 PAP prostate tumor after castration and estrogen treatment.
Lindström P; Bergh A; Holm I; Damber JE
Prostate; 1996 Oct; 29(4):209-18. PubMed ID: 8876704
[TBL] [Abstract][Full Text] [Related]
5. Alterations of transforming growth factor beta1 (TGF-beta1) and TGFbeta receptor expressions with progression in Dunning rat prostatic adenocarcinoma sublines.
Wikström P; Lindh G; Bergh A; Damber JE
Urol Res; 1999 Jun; 27(3):185-93. PubMed ID: 10422820
[TBL] [Abstract][Full Text] [Related]
6. Castration induces apoptosis in the ventral prostate but not in an androgen-sensitive prostatic adenocarcinoma in the rat.
Brändström A; Westin P; Bergh A; Cajander S; Damber JE
Cancer Res; 1994 Jul; 54(13):3594-601. PubMed ID: 8012987
[TBL] [Abstract][Full Text] [Related]
7. Modulation of transforming growth factor beta 1 effects on prostate cancer cell proliferation by growth factors and extracellular matrix.
Morton DM; Barrack ER
Cancer Res; 1995 Jun; 55(12):2596-602. PubMed ID: 7780974
[TBL] [Abstract][Full Text] [Related]
8. Possible involvement of TGF beta 1 in the distinct tumorigenic properties of two rat colon carcinoma clones.
Grégoire M; Garrigue L; Blottière HM; Denis MG; Meflah K
Invasion Metastasis; 1992; 12(3-4):185-96. PubMed ID: 1338201
[TBL] [Abstract][Full Text] [Related]
9. Expression of transforming growth factor-beta receptor type I and type II in rat ventral prostate and Dunning R3327 PAP adenocarcinoma in response to castration and oestrogen treatment.
Wikström P; Bergh A; Damber JE
Urol Res; 1997; 25(2):103-11. PubMed ID: 9144876
[TBL] [Abstract][Full Text] [Related]
10. TGF-beta1 in colonic neoplasia: a genetic molecular and immunohistochemical study.
Cardillo MR; Yap E
J Exp Clin Cancer Res; 1997 Sep; 16(3):281-8. PubMed ID: 9387902
[TBL] [Abstract][Full Text] [Related]
11. TGF beta in prostate cancer: a growth inhibitor that can enhance tumorigenicity.
Barrack ER
Prostate; 1997 Apr; 31(1):61-70. PubMed ID: 9108888
[TBL] [Abstract][Full Text] [Related]
12. Promotion of angiogenesis by ps20 in the differential reactive stroma prostate cancer xenograft model.
McAlhany SJ; Ressler SJ; Larsen M; Tuxhorn JA; Yang F; Dang TD; Rowley DR
Cancer Res; 2003 Sep; 63(18):5859-65. PubMed ID: 14522910
[TBL] [Abstract][Full Text] [Related]
13. Expression and regulation of transforming growth factor-beta 1 messenger ribonucleic acid and protein in cultured porcine Leydig and Sertoli cells.
Avallet O; Vigier M; Leduque P; Dubois PM; Saez JM
Endocrinology; 1994 May; 134(5):2079-87. PubMed ID: 8156908
[TBL] [Abstract][Full Text] [Related]
14. Effects of transforming growth factor-beta1 on parathyroid hormone-related protein mRNA expression and protein secretion in canine prostate epithelial, stromal, and carcinoma cells.
Sellers RS; LeRoy BE; Blomme EA; Tannehill-Gregg S; Corn S; Rosol TJ
Prostate; 2004 Mar; 58(4):366-73. PubMed ID: 14968437
[TBL] [Abstract][Full Text] [Related]
15. Expression of transforming growth factor alpha (TGF alpha) in differentiated rat mammary tumors: estrogen induction of TGF alpha production.
Liu SC; Sanfilippo B; Perroteau I; Derynck R; Salomon DS; Kidwell WR
Mol Endocrinol; 1987 Oct; 1(10):683-92. PubMed ID: 2484711
[TBL] [Abstract][Full Text] [Related]
16. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
[TBL] [Abstract][Full Text] [Related]
17. Estrogen induces apoptosis in a rat prostatic adenocarcinoma: association with an increased expression of TGF-beta 1 and its type-I and type-II receptors.
Landström M; Eklöv S; Colosetti P; Nilsson S; Damber JE; Bergh A; Funa K
Int J Cancer; 1996 Aug; 67(4):573-9. PubMed ID: 8759618
[TBL] [Abstract][Full Text] [Related]
18. Developmental and hormonal regulation of transforming growth factor-beta1 (TGFbeta1), -2, and -3 gene expression in isolated prostatic epithelial and stromal cells: epidermal growth factor and TGFbeta interactions.
Itoh N; Patel U; Cupp AS; Skinner MK
Endocrinology; 1998 Mar; 139(3):1378-88. PubMed ID: 9492075
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
[TBL] [Abstract][Full Text] [Related]
20. Incidence of apoptosis and cell proliferation in prostate cancer: relationship with TGF-beta1 and bcl-2 expression.
Tu H; Jacobs SC; Borkowski A; Kyprianou N
Int J Cancer; 1996 Oct; 69(5):357-63. PubMed ID: 8900367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
